A Novel Vitamin K<sub>1</sub> 2,3-Epoxide Reductase (VKOR) Inhibitor, 3-Acetyl-5-Methyltetronic Acid, Reduces Experimental Glomerulonephritis-Reference-Cited by-同舟云学术

A Novel Vitamin K₁ 2,3-Epoxide Reductase (VKOR) Inhibitor, 3-Acetyl-5-Methyltetronic Acid, Reduces Experimental Glomerulonephritis

Published:2012 Issue:7 Volume:74 Page:863-869
ISSN:0916-7250
Container-title:Journal of Veterinary Medical Science
language:en
Short-container-title:The Journal of Veterinary Medical Science

Author:

UCHIDA Masashi¹,SAKAGUCHI Yuka¹,MIYAMOTO Yohei¹

Affiliation:

1. Toxicology and Pharmacokinetics Laboratories, Pharmaceutical Research Laboratories, Toray Industries, Inc., 6–10–1 Tebiro, Kamakura, Kanagawa 248–8555, Japan

Publisher

Japanese Society of Veterinary Science

Subject

General Veterinary

Link

https://www.jstage.jst.go.jp/article/jvms/74/7/74_11-0530/_pdf

Reference45 articles.

1. 1. Bentley, E. W. 1972. A review of anticoagulant rodenticides in current use. Bull. World Health Organ. 47: 275–280.

2. 2. Bjornsson, T. D. 1979. Use of serum creatinine concentrations to determine renal function. Clin. Pharmacokinet. 4: 200–222.

3. 3. Brewster, U. C. and Perazella, M. A. 2004. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease. Am. J. Med. 116: 263–272.

4. 4. Brodsky, S. V., Satoskar, A., Chen, J. and Nadasdy, G. 2009. Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases. Am. J. Kidney Dis. 54: 1121–1126.

5. 5. Brodsky, S. V., Nadasdy, T., Rovin, B. H. and Satoskar, A. A. 2011. Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. Kidney Int. 80: 181–189.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DIBc nano metal-organic framework improves biochemical and pathological parameters of experimental chronic kidney disease;Journal of Trace Elements in Medicine and Biology;2020-09

BCc1 Nanomedicine Therapeutic Effects in Streptozotocin and High-Fat Diet Induced Diabetic Kidney Disease

;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2020-04

3. BCc1 Nanomedicine Therapeutic Effects in Streptozotocin and High-Fat Diet Induced Diabetic Kidney Disease;DIABET METAB SYND OB;2020

4. Pharmacological effects of a vitamin K₁ 2,3-epoxide reductase (VKOR) inhibitor, 3-acetyl-5-methyltetronic acid, on cisplatin-induced fibrosis in rats;Journal of Veterinary Medical Science;2017

5. Combination therapy with spironolactone and candesartan protects against streptozotocin-induced diabetic nephropathy in rats;European Journal of Pharmacology;2014-12